ES2159287T3 - Peptidos hemorreguladores. - Google Patents

Peptidos hemorreguladores.

Info

Publication number
ES2159287T3
ES2159287T3 ES93903011T ES93903011T ES2159287T3 ES 2159287 T3 ES2159287 T3 ES 2159287T3 ES 93903011 T ES93903011 T ES 93903011T ES 93903011 T ES93903011 T ES 93903011T ES 2159287 T3 ES2159287 T3 ES 2159287T3
Authority
ES
Spain
Prior art keywords
hemorregulating
peptides
compounds
fungal
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93903011T
Other languages
English (en)
Inventor
Pradip Kumar Bhatnagar
William Francis Huffman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of ES2159287T3 publication Critical patent/ES2159287T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA GENERAL (I). LOS COMPUESTOS TIENEN ACTIVIDADES HEMORREGULADORAS Y PUEDEN SER USADAS PARA ESTIMULAR LA HEMATOPOIESIS Y PARA LA PREVENCION Y TRATAMIENTO ENFERMEDADES INFECCIOSAS VIRALES O FUNGICIDAS Y BACTERICIDAS.
ES93903011T 1992-01-10 1993-01-08 Peptidos hemorreguladores. Expired - Lifetime ES2159287T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81902492A 1992-01-10 1992-01-10

Publications (1)

Publication Number Publication Date
ES2159287T3 true ES2159287T3 (es) 2001-10-01

Family

ID=25227024

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93903011T Expired - Lifetime ES2159287T3 (es) 1992-01-10 1993-01-08 Peptidos hemorreguladores.

Country Status (14)

Country Link
EP (1) EP0621788B1 (es)
JP (1) JPH07505864A (es)
CN (1) CN1077960A (es)
AT (1) ATE201693T1 (es)
AU (1) AU666516B2 (es)
CA (1) CA2127688A1 (es)
DE (1) DE69330268T2 (es)
ES (1) ES2159287T3 (es)
IL (1) IL104323A0 (es)
MX (1) MX9300100A (es)
NZ (1) NZ246805A (es)
SI (1) SI9300011A (es)
WO (1) WO1993013789A1 (es)
ZA (1) ZA93129B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69420044T2 (de) * 1993-10-29 2000-03-23 Smithkline Beecham Corp., King Of Prussia Blutregulierende peptide
GB9425730D0 (en) * 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
JP2000500461A (ja) * 1995-11-13 2000-01-18 スミスクライン・ビーチャム・コーポレイション 血液調節化合物
US5767135A (en) * 1995-12-29 1998-06-16 Fernandez-Pol; Jose Alberto Antiviral agent
US6579891B1 (en) 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
US6743771B2 (en) 1995-12-29 2004-06-01 Novactyl, Inc. Methods and compositions for controlling protein assembly or aggregation
US6127393A (en) 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
US6407125B1 (en) 1995-12-29 2002-06-18 Novactyl, Inc. Pharmacological agent and method of treatment
US6441009B1 (en) 1998-08-01 2002-08-27 Novactyl, Inc. Agent and method of preventing and treating heavy metal exposure and toxicity
US6403618B1 (en) 2000-02-15 2002-06-11 Novactyl, Inc. Agent and method for controlling angiogenesis
FR2966827B1 (fr) 2010-10-27 2014-08-22 Kimonella Ventures Ltd Compose peptidique utile pour l'inhibition de la formation de plaques amyloides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA838780B (en) * 1982-11-26 1985-01-30 Nyegaard & Co As Peptide compounds
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds
NO884054D0 (no) * 1988-09-13 1988-09-13 Bio Tech As Nytt pentapeptid og fremgangsmaate for fremstilling derav.
GB8821785D0 (en) * 1988-09-16 1988-10-19 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides
GB9211677D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
AU4340393A (en) * 1992-06-02 1993-12-30 Hafslund Nycomed As Double chain peptide compounds having hemoregulatory activity

Also Published As

Publication number Publication date
MX9300100A (es) 1994-04-29
AU666516B2 (en) 1996-02-15
NZ246805A (en) 1995-12-21
SI9300011A (en) 1993-09-30
CA2127688A1 (en) 1993-07-22
EP0621788A4 (en) 1997-03-05
AU3440293A (en) 1993-08-03
EP0621788B1 (en) 2001-05-30
EP0621788A1 (en) 1994-11-02
DE69330268D1 (de) 2001-07-05
CN1077960A (zh) 1993-11-03
WO1993013789A1 (en) 1993-07-22
JPH07505864A (ja) 1995-06-29
ATE201693T1 (de) 2001-06-15
IL104323A0 (en) 1993-05-13
ZA93129B (en) 1994-01-18
DE69330268T2 (de) 2001-11-22

Similar Documents

Publication Publication Date Title
DE69831506D1 (en) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
DK0973735T3 (da) Polyaromatiske antivirale præparater
ES2134764T3 (es) Inhibidores de hiv proteasa.
ATE245977T1 (de) Therapeutische substituierte guanidine
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
ATE157877T1 (de) Verbindung von nucleocidanaloga zur behandlung viraler infektionen
ES2159287T3 (es) Peptidos hemorreguladores.
ATE112289T1 (de) Hämoregulierende peptide.
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DE69514928D1 (de) Gegen protozoen wirksamezyklische tetrapeptide
BR9611520A (pt) Composto hemo-reguladores.
NO933628L (no) Fremgangsmaate og blanding for behandling av Herpes-infeksjoner

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 621788

Country of ref document: ES